Blockade or deletion of IFNg reduces macrophage activation without compromising CAR-T function in hematologic malignancies.
暂无分享，去创建一个
Matthew J. Frigault | M. Maus | Stefanie R. Bailey | R. Larson | M. Wehrli | M. Leick | A. Schmidts | Amanda A. Bouffard | M. Kann | Kevin A Lindell | Trisha R. Berger | Harrison Silva | Sonika Vatsa | Irene Scarfò | Ashley Demato | Kathleen ME Gallagher | M. Frigault | Kathleen M E Gallagher